Chronic myeloid leukaemia: open trials in Netherlands

10 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07354074
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Utrecht
Registry updated 2026-10-15
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Princess Máxima Center for Pediatric Oncology, Utrecht
Registry updated 2026-10-09
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Utrecht
Registry updated 2026-09-25
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
University Medical Center Groningen, Groningen
Registry updated 2026-09-15
2025-522138-29-00
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Trial Treatment · Phase 2 · Novartis Pharma AG
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-08-31
NCT07719348
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
Trial Treatment · Phase 1/2 · Servier
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Academisch Ziekenhuis Maastricht, Maastricht · Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-07-22
NCT04581512
Study to Evaluate the Safety and Tolerability of EP0042
Trial Treatment · Phase 1/2 · Ellipses Pharma
VUMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-06-22
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Trial Treatment · Phase 1 · Enliven Therapeutics
Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-04-01
2024-515409-25-00
A multicenter trial where patients with CML stop medication a second time.
Trial Treatment · Phase 2 · Region Uppsala
Amsterdam UMC Stichting, Amsterdam
Registry updated 2025-03-03
NCT01281735
International Chronic Myeloid Leukemia Pediatric Study
Research · Poitiers University Hospital
Dutch Childhood Oncology Group, Princess Maxima Center for pediatric oncology, Utrecht
Registry updated 2024-01-17

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error